furazolidone has been researched along with Acute Myelogenous Leukemia in 1 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furazolidone (FZD) was shown to inhibit bone marrow transformation mediated by several leukemia fusion proteins, including AML1-ETO." | 1.39 | A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia. ( Dong, S; Jiang, X; Li, S; Qiu, JJ; So, CW; Sun, L; Sun, X; Wang, X, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, X | 1 |
| Sun, L | 1 |
| Qiu, JJ | 1 |
| Sun, X | 1 |
| Li, S | 1 |
| Wang, X | 1 |
| So, CW | 1 |
| Dong, S | 1 |
1 other study available for furazolidone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Antitrichomonal Agents; Apoptosis; Biological Assay; Cell Differenti | 2013 |